Mid-face Toddler Excoriation Syndrome (MiTES): A new conundrum in the field?

an enigma in sensory neuropathy

Authors

  • Abhineetha Hosthota The Oxford Medical College Hospital & Research Centre
  • Swapna Bondade The Oxford Medical College Hospital And Research Centre
  • Bhavana V The Oxford Medical College Hospital And Research Centre
  • Sanjay Thejesvi The Oxford Medical College Hospital And Research Centre

DOI:

https://doi.org/10.66344/jpad.33.1.2023.2027

Keywords:

Excoriation, neuropathy, midface

Abstract

Genetically heterogeneous group of sensory neuropathies have variable clinical presentation with insensitivity to pain as a prime feature. Chronic scarring with midface erosions mostly found in infants and toddlers and may be the only primary manifestation of chronic insensitivity to pain. In these cases, parents report that lesions are self-induced but, doctors attribute fabricated illness by parents. Thorough clinical and laboratory workup has to be done to distinguish between sensory neuropathies, Factious illness and neurometabolic disease. Midface toddler excoriation syndrome is a recently described entity, clinically characterized by excoriations and sequelae of long-term scratching, over mid-face in toddlers. In this case we have proposed the recognition of this entity in young adult, would encourage further scientific reports, and help to elucidate the cause.

Author Biographies

Swapna Bondade, The Oxford Medical College Hospital And Research Centre

Professor & Head  Department of Psychiatry 

Bhavana V, The Oxford Medical College Hospital And Research Centre

Junior Resident  Department of Dermatology

Sanjay Thejesvi, The Oxford Medical College Hospital And Research Centre

Assistant Professor  Department of Dermatology 

References

Chen Y-C, Auer-Grumbach M, Matsukawa S, Zitzelsberger M, Themistocleous AC, Strom TM, et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat Genet. 2015;47(8):803-8.

Elhennawy K, Reda S, Finke C, Graul-Neumann L, Jost-Brinkmann PG, Bartzela T. Oral manifestations, dental management, and a rare homozygous mutation of the PRDM12 gene in a boy with hereditary sensory and autonomic neuropathy type VIII: a case report and review of the literature. J Med Case Rep. 2017;11(1):233.

Srinivas SM, Gowda VK, Owen CM, Moss C, Hiremagalore R. Midface toddler excoriation syndrome (MiTES): a new paediatric diagnosis. Clin Exp Dermatol. 2017;42(1):68-71.

Moss C, Srinivas SM, Sarveswaran N, Nahorski M, Gowda VK, Browne FM, et al. Midface toddler excoriation syndrome (MiTES) can be caused by autosomal recessive biallelic mutations in a gene for congenital insensitivity to pain, PRDM12. Br J Dermatol. 2018;179(5):1135-40.

Kumar P, Das A. Midface toddler excoriation syndrome. Indian J Dermatol Venereol Leprol 2021;87(4):528-9.

Moss C. Dermatitis artefacta in children and adolescents. Paediatric Child Health. 2015; 25(2):84-9.

T. Narang, S. Singh. Response to: Midface toddler excoriation syndrome (MiTES) can be caused by autosomal recessive biallelic mutations in a gene for congenital insensitivity to pain, PRDM12. Br J Dermatol. 2019;180(2):431.

Downloads

Published

2023-03-05

How to Cite

1.
Hosthota A, Bondade S, V B, Thejesvi S. Mid-face Toddler Excoriation Syndrome (MiTES): A new conundrum in the field? an enigma in sensory neuropathy . J Pak Assoc Dermatol [Internet]. 2023Mar.5 [cited 2026Apr.12];33(1):335-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2027

Issue

Vol. 33 No. 1 (2023): January-March

Section

Case Reports

License

Submission declaration

Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.

By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.